The psychosis risk gene RBM12 encodes a novel repressor of GPCR/cAMP signal transduction II
To investigate beta-2-adrenergic targets in RBM12-depleted neurons derived from the parental WTc11 iPSC line Overall design: Comparative gene expression profiling analysis of RNA-seq data of RBM12-depleted glutamatergic excitatory neurons derived from the parental WTc11 iPSC line, untreated or treated with isoproterenol (beta-2-adrenergic receptor agonist)